In MGMT-silenced tumors, which are typically more responsive to TMZ, selective treatment pressure frequently leads to acquired mismatch repair (MMR) deficiency, most often through mutations in MSH69–13. Here, MGMT is linked to hyperinsulinemic hypoglycemia, familial, 4.